I Busilvex- forsøgene afgik en patient ved døden på grund af shocklunge - acute respiratory distress syndrome - fulgt af respirationssvigt forbundet med interstitiel lungefibrose.
One patient experienced a fatal case of acute respiratory distress syndrome with subsequent respiratory failure associated with interstitial pulmonary fibrosis in the Busilvex studies.